Skip to main content

Table 1 Inclusion/exclusion criteria

From: A randomized control trial to assess the impact of vitamin D supplementation compared to placebo on vascular stiffness in chronic kidney disease patients

Inclusion criteria Exclusion criteria
- Signed informed consent - Refused informed consent
- eGFR between 15-45 ml/min - Change of >5ml/min eGFR over the past 6 months
- Change of <5ml/min in eGFR over the past 6 months - Planned transplant within 6 months
- Treated with maximal conventional CV disease risk reduction protocolized medications (ACEi or ARB) - Likely to commence renal replacement therapy within 6 months after enrolment
- Currently receiving vitamin D therapies, but agreeing to a washout period of 3 months - Terminal malignancies
  - Active infections
  - Active inflammatory diseases (SLE, vasculitis)